skip to main content

Ivabradine eligibility — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardCardiovascular TherapeuticsIvabradine eligibilityGPhC CRA

A GP asks about ivabradine for a patient with heart failure who remains symptomatic despite treatment. The patient is in atrial fibrillation with a resting heart rate of 96 beats per minute. What is the most appropriate alternative?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EOptimise standard heart failure and rate-control therapy rather than ivabradine

Ivabradine reduces heart rate by acting on the sinus node and is not effective for rate control in atrial fibrillation. It has specific criteria in heart failure, including sinus rhythm and appropriate heart-rate threshold. Atrial fibrillation requires separate rate or rhythm management and stroke prevention assessment. Verapamil is also problematic in many patients with reduced ejection fraction.

Reference: BNF; NICE CKS